0001209191-17-029465.txt : 20170502 0001209191-17-029465.hdr.sgml : 20170502 20170502205117 ACCESSION NUMBER: 0001209191-17-029465 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170428 FILED AS OF DATE: 20170502 DATE AS OF CHANGE: 20170502 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Pulse Biosciences, Inc. CENTRAL INDEX KEY: 0001625101 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 465696597 STATE OF INCORPORATION: NV FISCAL YEAR END: 1217 BUSINESS ADDRESS: STREET 1: 849 MITTEN ROAD STREET 2: SUITE 104 CITY: BURLINGAME STATE: CA ZIP: 94010 BUSINESS PHONE: 650-697-3939 MAIL ADDRESS: STREET 1: 849 MITTEN ROAD STREET 2: SUITE 104 CITY: BURLINGAME STATE: CA ZIP: 94010 FORMER COMPANY: FORMER CONFORMED NAME: Electroblate, Inc. DATE OF NAME CHANGE: 20141113 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DUGGAN ROBERT W CENTRAL INDEX KEY: 0001055919 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37744 FILM NUMBER: 17806923 MAIL ADDRESS: STREET 1: 611 SOUTH FORT HARRISON AVE STREET 2: SUITE 306 CITY: CLEARWATER STATE: FL ZIP: 33756 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-04-28 0 0001625101 Pulse Biosciences, Inc. PLSE 0001055919 DUGGAN ROBERT W 611 S. FORT HARRISON AVE., SUITE 306 CLEARWATER FL 33756 0 0 1 0 Common Stock 2017-04-28 4 P 0 25000 23.85 A 2958579 D Common Stock 2017-05-01 4 P 0 19348 23.812 A 2977927 D Common Stock 2017-05-02 4 P 0 5000 23.40 A 2982927 D Common Stock 2017-04-28 4 P 0 35000 24.00 A 35000 I See footnote This is the weighted average purchase price of the shares, which ranged from $23.362 to $23.989 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4. Shares are held by Genius Accelerated LLC, of which the Reporting Person is the sole member and beneficiary. Brian Dow, as Attorney-in-Fact for Robert W. Duggan 2017-05-02